Printer Friendly

Laurane Medical SAS introduces The OmniBone(TM) Biopsy System.

The New Omnibone(TM) Technology offers a sophisticated approach to bone biopsy procedures

PARIS, Oct. 8, 2015 /PRNewswire/ -- Laurane Medical SAS announced today the pre-launch of the OmniBone(TM) Biopsy System which combines a direct or wire guided approach with an option to switch from a manual introduction to a power-driven operation at any time during the procedure.

"The OmniBone(TM) Biopsy System will offer our customers an all-in-one kit which is unique and incredibly versatile," says Laurent Fumex, President and Founder of Laurane Medical SAS. "The physician can choose between a direct or wire guided approach and then has the option to switch from a manual device to a power driven operation. This flexibility offers exceptional biopsy efficiency and increased precision when performing a bone biopsy procedure."

The OmniBone(TM) Biopsy System features:

* Perforating grooved introducer for immediate bone purchase and controlled access,

* Wire guided introduction if necessary for unparalleled precision,

* Removable handles for ease of use,

* Option to switch from manual to power drill at any time during the procedure.

About Laurane Medical SAS

Laurane Medical SAS is a small innovative incubator specialized in cutting edge medical device technology in the fields of interventional radiology and orthopedic surgery. Laurane Medical SAS has developed several new products, among which the pioneer invention of the all suture anchor. This technology was acquired by STRYKER in 2011 and led to the ICONIX All Suture Anchor Platform launched in 2013.

To view the original version on PR Newswire, visit:

SOURCE Laurane Medical SAS

COPYRIGHT 2015 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:4EUFR
Date:Oct 8, 2015
Previous Article:BIOMED REALTY INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in...
Next Article:CONE Midstream Schedules Earnings Release And Conference Call For Third Quarter Results.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters